• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

TACE with or without systemic therapy?

作者信息

Dufour Jean-François

出版信息

J Hepatol. 2012 Jun;56(6):1224-5. doi: 10.1016/j.jhep.2012.02.011. Epub 2012 Mar 5.

DOI:10.1016/j.jhep.2012.02.011
PMID:22402292
Abstract
摘要

相似文献

1
TACE with or without systemic therapy?肝动脉化疗栓塞术联合或不联合全身治疗？
J Hepatol. 2012 Jun;56(6):1224-5. doi: 10.1016/j.jhep.2012.02.011. Epub 2012 Mar 5.
2
Safety of transarterial chemoembolization plus sorafenib combination treatment in unresectable hepatocellular carcinoma.经动脉化疗栓塞联合索拉非尼治疗不可切除肝细胞癌的安全性
Scand J Gastroenterol. 2010 Apr;45(4):511-2. doi: 10.3109/00365521003628335.
3
Major achievements in hepatocellular carcinoma.肝细胞癌的主要成就。
Lancet. 2009 Feb 21;373(9664):614-6. doi: 10.1016/S0140-6736(09)60381-0.
4
Sorafenib, doesn't it have any competitor in advanced hepatocellular carcinoma?索拉非尼在晚期肝细胞癌领域难道没有任何竞争对手吗？
J Gastroenterol Hepatol. 2011 Nov;26(11):1585-6. doi: 10.1111/j.1440-1746.2011.06901.x.
5
Potential impact of sorafenib on the survival benefit of liver transplantation for hepatocellular carcinoma.索拉非尼对肝细胞癌肝移植生存获益的潜在影响。
Dig Liver Dis. 2012 May;44(5):361-2. doi: 10.1016/j.dld.2012.02.014. Epub 2012 Mar 14.
6
Transarterial therapies for hepatocellular carcinoma (HCC): a long way towards standardization.肝细胞癌（HCC）的经动脉治疗：迈向标准化的漫长道路。
J Hepatol. 2013 Jan;58(1):194. doi: 10.1016/j.jhep.2012.08.028. Epub 2012 Oct 6.
7
Intra-arterial infusion of chemotherapy for advanced hepatocellular carcinoma: an Asian perspective.
Asia Pac J Clin Oncol. 2012 Jun;8(2):111-4. doi: 10.1111/j.1743-7563.2012.01551.x.
8
Reply to: "Transarterial therapies for hepatocellular carcinoma (HCC): a long way towards standardization".
J Hepatol. 2013 Jan;58(1):195. doi: 10.1016/j.jhep.2012.09.033. Epub 2012 Oct 6.
9
[Clinical observation of the treatment with combination of transcatheter arterial chemoembolization and sorafenib for hepatocellular carcinoma with lung metastasis].经导管动脉化疗栓塞术联合索拉非尼治疗肝细胞癌肺转移的临床观察
Zhonghua Zhong Liu Za Zhi. 2009 Sep;31(9):716-8.
10
Early evaluation of transcatheter arterial chemoembolization-refractory hepatocellular carcinoma.经导管动脉化疗栓塞耐药性肝细胞癌的早期评估。
J Gastroenterol. 2012 Mar;47(3):343-6. doi: 10.1007/s00535-011-0511-x. Epub 2011 Dec 21.

引用本文的文献

1
Predicting Outcome in Combination Treatment of TACE and Camrelizumab for Advanced Hepatocellular carcinoma: Tumor Hypervascularity and Reactive Cutaneous Capillary Endothelial Proliferation.预测 TACE 联合卡瑞利珠单抗治疗晚期肝细胞癌的疗效：肿瘤富血管性和反应性皮肤毛细血管内皮细胞增生。
Drug Des Devel Ther. 2022 Sep 30;16:3421-3429. doi: 10.2147/DDDT.S372276. eCollection 2022.
2
Radiologic Response Combined with Dermatologic Toxicities is the Most Robust Predictor of Survival Benefits in Patients with Inoperable Hepatocellular Carcinoma After Transarterial Chemoembolization Plus Sorafenib Therapy.经动脉化疗栓塞术联合索拉非尼治疗后不可切除的肝细胞癌患者的生存获益与放射学反应和皮肤毒性最相关。
Cardiovasc Intervent Radiol. 2021 Sep;44(9):1394-1402. doi: 10.1007/s00270-021-02846-w. Epub 2021 May 4.
3
Exploratory Analysis to Identify Candidates Benefitting from Combination Therapy of Transarterial Chemoembolization and Sorafenib for First-Line Treatment of Unresectable Hepatocellular Carcinoma: A Multicenter Retrospective Observational Study.探索性分析以确定从经动脉化疗栓塞术与索拉非尼联合治疗中获益的不可切除肝细胞癌一线治疗候选者：一项多中心回顾性观察研究
Liver Cancer. 2020 Jun;9(3):308-325. doi: 10.1159/000505692. Epub 2020 Feb 19.
4
Tumor Hypervascularity and hand-foot-skin reaction predict better outcomes in combination treatment of TACE and Sorafenib for intermediate hepatocellular carcinoma.肿瘤富血管化和手足皮肤反应预测索拉非尼联合 TACE 治疗中晚期肝癌有更好的疗效。
BMC Cancer. 2019 Apr 30;19(1):409. doi: 10.1186/s12885-019-5570-z.
5
Transarterial chemoembolization for the treatment of hepatocellular carcinoma: a review.经动脉化疗栓塞治疗肝细胞癌：综述
J Hepatocell Carcinoma. 2017 Jul 27;4:105-110. doi: 10.2147/JHC.S103661. eCollection 2017.
6
Current systemic treatment of hepatocellular carcinoma: A review of the literature.肝细胞癌的当前全身治疗：文献综述
World J Hepatol. 2015 Jun 8;7(10):1412-20. doi: 10.4254/wjh.v7.i10.1412.
7
CKAP4 inhibited growth and metastasis of hepatocellular carcinoma through regulating EGFR signaling.CKAP4通过调节表皮生长因子受体（EGFR）信号通路抑制肝细胞癌的生长和转移。
Tumour Biol. 2014 Aug;35(8):7999-8005. doi: 10.1007/s13277-014-2000-3. Epub 2014 May 18.
8
Combination of local transcatheter arterial chemoembolization and systemic anti-angiogenic therapy for unresectable hepatocellular carcinoma.局部经导管动脉化疗栓塞与全身抗血管生成治疗联合用于不可切除肝细胞癌
Liver Cancer. 2012 Nov;1(3-4):201-15. doi: 10.1159/000343835.